CBLB (Cbl proto-oncogene B)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
868 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Cbl proto-oncogene B |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
CBLB |
SynonymsGene synonyms aliases
|
ADMIO3, Cbl-b, Nbla00127, RNF56 |
ChromosomeChromosome number
|
3 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
3q13.11 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes an E3 ubiquitin-protein ligase which promotes proteosome-mediated protein degradation by transferring ubiquitin from an E2 ubiquitin-conjugating enzyme to a substrate. The encoded protein is involved in the regulation of immune response |
miRNAmiRNA information provided by mirtarbase database.
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0001784 |
Function |
Phosphotyrosine residue binding |
IEA |
|
GO:0002669 |
Process |
Positive regulation of T cell anergy |
IEA |
|
GO:0005509 |
Function |
Calcium ion binding |
IEA |
|
GO:0005515 |
Function |
Protein binding |
IPI |
10022120, 12177062, 12577067, 16189514, 17020880, 17255943, 18680311, 19268472, 19380743, 20598684, 20936779, 21706016, 21900206, 23663663, 25218436, 25416956, 25814554, 26871637, 27107012, 28514442, 29237719, 29513927, 29997244, 31467278, 31515488, 31980649, 32296183, 32814053 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005829 |
Component |
Cytosol |
IDA |
|
GO:0005886 |
Component |
Plasma membrane |
IBA |
21873635 |
GO:0006607 |
Process |
NLS-bearing protein import into nucleus |
TAS |
7784085 |
GO:0006955 |
Process |
Immune response |
IEA |
|
GO:0007165 |
Process |
Signal transduction |
IBA |
21873635 |
GO:0007175 |
Process |
Negative regulation of epidermal growth factor-activated receptor activity |
IBA |
21873635 |
GO:0008270 |
Function |
Zinc ion binding |
TAS |
7784085 |
GO:0016567 |
Process |
Protein ubiquitination |
IEA |
|
GO:0017124 |
Function |
SH3 domain binding |
IBA |
21873635 |
GO:0018193 |
Process |
Peptidyl-amino acid modification |
IEA |
|
GO:0030971 |
Function |
Receptor tyrosine kinase binding |
IBA |
21873635 |
GO:0031398 |
Process |
Positive regulation of protein ubiquitination |
IEA |
|
GO:0035556 |
Process |
Intracellular signal transduction |
IEA |
|
GO:0042110 |
Process |
T cell activation |
IEA |
|
GO:0043087 |
Process |
Regulation of GTPase activity |
IEA |
|
GO:0043393 |
Process |
Regulation of protein binding |
IEA |
|
GO:0045121 |
Component |
Membrane raft |
IBA |
21873635 |
GO:0045732 |
Process |
Positive regulation of protein catabolic process |
IEA |
|
GO:0046642 |
Process |
Negative regulation of alpha-beta T cell proliferation |
IEA |
|
GO:0050852 |
Process |
T cell receptor signaling pathway |
IEA |
|
GO:0050860 |
Process |
Negative regulation of T cell receptor signaling pathway |
IEA |
|
GO:0061630 |
Function |
Ubiquitin protein ligase activity |
IBA |
21873635 |
GO:2000583 |
Process |
Regulation of platelet-derived growth factor receptor-alpha signaling pathway |
ISS |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q13191 |
Protein name |
E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B) |
Protein function |
E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome. Negatively regulates TCR (T-cell receptor), BCR (B-cell |
PDB |
2AK5
,
2BZ8
,
2DO6
,
2J6F
,
2JNH
,
2LDR
,
2OOA
,
2OOB
,
3PFV
,
3VGO
,
3ZNI
,
8GCY
,
8QNG
,
8QNH
,
8QNI
,
8QTG
,
8QTH
,
8QTJ
,
8QTK
,
8VW4
,
8VW5
,
9FQH
,
9FQI
,
9FQJ
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF02262 |
Cbl_N |
41 → 167 |
CBL proto-oncogene N-terminal domain 1 |
Domain |
PF02761 |
Cbl_N2 |
171 → 254 |
CBL proto-oncogene N-terminus, EF hand-like domain |
Domain |
PF02762 |
Cbl_N3 |
256 → 341 |
CBL proto-oncogene N-terminus, SH2-like domain |
Domain |
PF14447 |
Prok-RING_4 |
373 → 426 |
|
Family |
|
Sequence |
|
Sequence length |
982 |
Interactions |
View interactions |
PathwaysPathway information has different metabolic/signaling pathways associated with genes. Each record is hyperlinked to a complete information page which also includes links to the KEGG/Reactome pathway database.
|
|
Associated diseases
|
Causal |
Disease name |
Disease term |
dbSNP ID |
References |
Hypothyroidism |
Hypothyroidism |
rs869320723, rs121908862, rs121908863, rs121908865, rs121908866, rs121908867, rs121908870, rs121908871, rs121908872, rs2140110277, rs121908881, rs121908884, rs121908885, rs786205080, rs1586182912, rs121917847, rs104893655, rs104893657, rs104893658, rs104893659, rs104893660, rs104893656, rs121917719, rs786204790, rs189261858, rs879255608, rs868197660, rs879255609, rs1586744173, rs1586182837, rs771222349, rs1587618417, rs1601844140, rs760832986, rs780982673, rs1603336347, rs1691155605 |
30595370 |
Leukemia |
Leukemia, Myelocytic, Acute |
rs121909646, rs121913488, rs587776834, rs752746786, rs869312821, rs767454740, rs1554564297, rs11978267, rs4132601 |
|
Multiple sclerosis |
Multiple Sclerosis, Multiple Sclerosis, Acute Fulminating |
rs104895219, rs483353022, rs483353023, rs483353028, rs483353029, rs483353024, rs483353030, rs3207617, rs483353031, rs483353032, rs483353033, rs483353034, rs483353035, rs483353036, rs483353039, rs483353038, rs61731956, rs568165874, rs767480544 |
28445677, 20453840, 20453840 |
|
|
|